Forskning ved Københavns Universitet - Københavns Universitet

Forside

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Jacek Capala
  • Kirsten Bouchelouche
HER2 overexpression is correlated with aggressive tumor behavior and poor clinical outcome. Therefore, HER2 has become an important prognostic and predictive factor, as well as a target for molecular therapies. The article reviews recent advances in molecular imaging of HER2 that could facilitate individual approaches to targeted therapy of HER2-positive breast cancers.
OriginalsprogEngelsk
TidsskriftCurrent Opinion in Oncology
Vol/bind22
Udgave nummer6
Sider (fra-til)559-66
Antal sider8
ISSN1040-8746
DOI
StatusUdgivet - 1 nov. 2010

ID: 34176082